Ken Griffin Good Rx Holdings, Inc. Transaction History

Citadel Advisors LLC

$550 Billion
Q2 2025

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Good Rx Holdings, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 1,623,236 shares of GDRX stock, worth $5.68 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,623,236

Previous 195,200 731.58%

Holding current value

$5.68 Million

Previous $860,000 839.88%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$3.74 - $5.07 $3.27 Million - $4.44 Million	874,913 Added 116.92%	1,623,236 $8.08 Million
Q1 2025 May 15, 2025	BUY	$4.15 - $5.13 $760,724 - $940,364	183,307 Added 32.44%	748,323 $3.3 Million
Q4 2024 Feb 14, 2025	BUY	$4.15 - $7.09 $1.37 Million - $2.34 Million	329,622 Added 140.03%	565,016 $2.63 Million
Q3 2024 Nov 14, 2024	SELL	$6.69 - $9.05 $373,576 - $505,361	-55,841 Reduced 19.17%	235,394 $1.64 Million
Q2 2024 Aug 14, 2024	BUY	$6.5 - $8.91 $1 Million - $1.38 Million	154,336 Added 112.74%	291,235 $2.27 Million
Q1 2024 May 15, 2024	SELL	$5.37 - $8.35 $72,736 - $113,100	-13,545 Reduced 9.0%	136,899 $971,000
Q4 2023 Feb 14, 2024	SELL	$4.44 - $6.7 $101,014 - $152,431	-22,751 Reduced 13.14%	150,444 $1.01 Million
Q3 2023 Nov 14, 2023	SELL	$5.23 - $9.24 $4.83 Million - $8.53 Million	-923,155 Reduced 84.2%	173,195 $975,000
Q2 2023 Aug 14, 2023	BUY	$4.36 - $6.2 $2.79 Million - $3.97 Million	640,874 Added 140.7%	1,096,350 $6.05 Million
Q1 2023 May 15, 2023	SELL	$4.71 - $6.66 $777,917 - $1.1 Million	-165,163 Reduced 26.61%	455,476 $2.85 Million
Q4 2022 Feb 14, 2023	BUY	$4.06 - $5.71 $2.42 Million - $3.4 Million	596,192 Added 2438.71%	620,639 $2.89 Million
Q3 2022 Nov 14, 2022	SELL	$4.67 - $7.81 $2.12 Million - $3.55 Million	-454,995 Reduced 94.9%	24,447 $114,000
Q2 2022 Aug 15, 2022	BUY	$5.84 - $20.02 $2.48 Million - $8.49 Million	423,994 Added 764.67%	479,442 $2.84 Million
Q1 2022 May 16, 2022	BUY	$13.62 - $32.45 $69,938 - $166,630	5,135 Added 10.21%	55,448 $1.07 Million
Q4 2021 Feb 14, 2022	BUY	$32.11 - $47.16 $95,366 - $140,065	2,970 Added 6.27%	50,313 $1.64 Million
Q3 2021 Nov 15, 2021	SELL	$29.63 - $46.98 $7.37 Million - $11.7 Million	-248,822 Reduced 84.01%	47,343 $1.94 Million
Q2 2021 Aug 16, 2021	BUY	$28.27 - $41.18 $4.43 Million - $6.46 Million	156,805 Added 112.52%	296,165 $10.7 Million
Q1 2021 May 17, 2021	BUY	$35.03 - $56.99 $1.88 Million - $3.07 Million	53,797 Added 62.87%	139,360 $5.44 Million
Q4 2020 Feb 16, 2021	SELL	$33.76 - $57.16 $604,270 - $1.02 Million	-17,899 Reduced 17.3%	85,563 $3.45 Million
Q3 2020 Nov 16, 2020	BUY	$46.7 - $56.79 $4.83 Million - $5.88 Million	103,462 New	103,462 $5.75 Million

Others Institutions Holding GDRX

# of Institutions

202

Shares Held

121M

Call Options Held

715K

Put Options Held

226K

View Full List

About GoodRx Holdings, Inc.

Ticker GDRX
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 84,394,800
Market Cap $295M
Description
GoodRx Holdings, Inc., through its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated pri...

More about GDRX

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account